Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial

ConclusionThis prespecified analysis of data from MONONOFU has confirmed that the efficacy of lasmiditan is rapid in onset and sustained in patients with moderate-to-severe migraine in Japan.Trial RegistrationClinicalTrials.gov (NCT03962738).

http://link.springer.com/10.1007/s40120-022-00403-2

Source: Neurology and Therapy - September 22, 2022 Category: Neurology Source Type: research